Central to this program will be vast knowledge share surrounding the identification of the most logical home for the patient advocacy function within an organization.
Communication strategies and regulatory considerations when working with international patient groups as well as creating a timeline for patient group integration among varying stages of product development will also be key topics of discussion. Attendees will also gain an insider perspective from patient group leaders regarding challenges and benefits of creating industry partnerships.
The program will provide participants with extensive networking as well as in-depth learning through interactive sessions, panel discussions and case studies, complemented by multiple networking opportunities with industry peers and patient advocate speakers.
Attendees will have the opportunity to learn strategies for overcoming key challenges involved in the patient advocacy relations role across the life science industry. Through fostering a sense of collaboration, this unique conference program will inspire innovation and help bring clarity to pharmaceutical and biotech patient advocacy relations professionals that wish to maximize their impact on the industry as well as within the patient community.
KEY CONFERENCE TAKEAWAYS
- Locating a Home for the Patient Advocacy Role and Analyzing Efficiencies
- Using Metrics to Develop Strategic Patient Advocacy Programs
- Sustaining a Robust On Boarding Criterion for Selecting Patient Groups
- Implications of the Patient Protection & Affordable Care Act on Patient Access to Treatment
- Patient Perspective Panel Discussion: Addressing Advantages and Challenges of Industry Partnerships
PRESENTATIONS TO INCLUDE:
Genzyme Cross-Functional Panel Discussion: Locating a Home for the Patient Advocacy Role and Analyzing Efficiencies
Jamie Ring, Vice President, Global Patient Advocacy- Rare Diseases, GENZYME
Dr. Timothy Miller, US Medical Director, Genetics, GENZYME
Rumana Haque-Ahmed, Senior Director Regulatory Affairs, GENZYME
Case Study: Using Metrics to Develop Strategic Patient Advocacy Programs
Valerie Carter, Senior Vice President, JONES PUBLIC AFFAIRS
Ken Deutsch, Executive Vice President, JONES PUBLIC AFFAIRS
Case Study: Sustaining a Robust On Boarding Criterion for Selecting Patient Groups
Kristen Binaso, Associate Director, Patient Advocacy & Professional Relations, BOEHRINGER INGELHEIM